"Clone-specific" antibody-drug conjugates: an innovative strategy in the treatment of T-cell cancers

Signal Transduct Target Ther. 2024 Sep 4;9(1):228. doi: 10.1038/s41392-024-01945-7.

Authors

Dennis Jungherz¹, Philipp Lückemeier¹, Marco Herling²

Affiliations

¹ Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany.
² Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany. [email protected].

No abstract available

MeSH terms

Humans
Immunoconjugates* / pharmacology
Immunoconjugates* / therapeutic use
T-Lymphocytes / drug effects
T-Lymphocytes / immunology

Substances

Immunoconjugates